Loading
MI
MyoKardia, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by GIANAKAKOS ANASTASIOS, was filed 08 Jan 2019.
MyoKardia, Inc.: what insiders have been doing
Every trade that managers of MyoKardia, Inc. disclose to SEC (Form 4) is tracked on this page. MyoKardia, Inc. has had no insider filing for more than a year; the last one goes back to 19 November 2020.
Looking back to 2016, when coverage begins, insiders filed 7 purchases and 153 sales.
In the same market, recent insider purchases at GameStop Corp. and Heico Corp also feature in our signals. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
309
Thresholds
n/a
Buy Volume
€23M
7 ops. · all time
Sell Volume
€281M
153 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2019FY ended December 2019 · cache
Income statement
Net income-246.2M
Last declaration on 19 November 2020
Declarations309 total
4,100 sharesCommon StockSEC:0000899243-20-031758:0
90,209 sharesCommon StockSEC:0000899243-20-031756:0
4,100 sharesCommon StockSEC:0000899243-20-031748:0
42,199 sharesCommon StockSEC:0000899243-20-031757:0
141,405 sharesCommon StockSEC:0000899243-20-031746:0
129,407 sharesCommon StockSEC:0000899243-20-031746:1
300,000 sharesCommon StockSEC:0000899243-20-031746:2
7,000 sharesCommon StockSEC:0000899243-20-031746:3
10,000 sharesCommon StockSEC:0000899243-20-031746:4
53,087 sharesCommon StockSEC:0000899243-20-031746:5
53,087 sharesCommon StockSEC:0000899243-20-031746:6
53,087 sharesCommon StockSEC:0000899243-20-031746:7
42,559 sharesCommon StockSEC:0000899243-20-031759:0
36,616 sharesCommon StockSEC:0000899243-20-031762:0
4,100 sharesCommon StockSEC:0000899243-20-031763:0
25,000 sharesCommon StockSEC:0000899243-20-031742:0
5,508 sharesCommon StockSEC:0000899243-20-031745:0
4,100 sharesCommon StockSEC:0000899243-20-031749:0
29,508 sharesCommon StockSEC:0000899243-20-031755:0
1,776 shares@ US$93.551.9% of flowCommon StockSEC:0000950123-20-006771:0
3,224 shares@ US$94.223.4% of flowCommon StockSEC:0000950123-20-006771:1
371 shares@ US$11.690.2% of flowCommon StockSEC:0000899243-20-018175:0
371 shares@ US$98.68211.5% of flowCommon StockSEC:0000899243-20-018175:1
21,629 shares@ US$11.6910.6% of flowCommon StockSEC:0000899243-20-018175:2
300 shares@ US$97.25471.2% of flowCommon StockSEC:0000899243-20-018175:3
25 of 309 declarations
About MyoKardia, Inc.
MyoKardia, Inc. is a biopharmaceutical company focused on developing treatments for genetic heart diseases. It emphasizes innovation in targeted therapies to improve patient outcomes.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations
